ERBB2 c.459C>A ;(p.V153=)

Variant ID: 17-37865590-C-A

NM_004448.2(ERBB2):c.459C>A;(p.V153=)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Development and Validation of a Targeted 'Liquid' NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer.

Diagnostics (Basel, Switzerland)
Kastrisiou, Myrto M; Zarkavelis, George G; Kougioumtzi, Anastasia A; Sakaloglou, Prodromos P; Kostoulas, Charilaos C; Georgiou, Ioannis I; Batistatou, Anna A; Pentheroudakis, George G; Magklara, Angeliki A
Publication Date: 2021-12-16

Variant appearance in text: ERBB2: V153V
PubMed Link: 34943612
Variant Present in the following documents:
  • Main text
  • diagnostics-11-02375.pdf
View BVdb publication page



Development and Validation of a Targeted 'Liquid' NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer.

Diagnostics (Basel, Switzerland)
Kastrisiou, Myrto M; Zarkavelis, George G; Kougioumtzi, Anastasia A; Sakaloglou, Prodromos P; Kostoulas, Charilaos C; Georgiou, Ioannis I; Batistatou, Anna A; Pentheroudakis, George G; Magklara, Angeliki A
Publication Date: 2021-12-16

Variant appearance in text: ERBB2: V153V
PubMed Link: 34943612
Variant Present in the following documents:
  • Main text
  • diagnostics-11-02375.pdf
View BVdb publication page